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Abstract
Background: The fully developed adult skeleton adapts to mechanical forces by generating more bone, usually at
the periosteal surface. Progenitor cells in the periosteum are believed to differentiate into bone-forming osteoblasts
that contribute to load-induced adult bone formation, but in vivo evidence does not yet exist. Furthermore, the
mechanism by which periosteal progenitors might sense physical loading and trigger differentiation is unknown.
We propose that periosteal osteochondroprogenitors (OCPs) directly sense mechanical load and differentiate into
bone-forming osteoblasts via their primary cilia, mechanosensory organelles known to be involved in osteogenic
differentiation.
Methods: We generated a diphtheria toxin ablation mouse model and performed ulnar loading and dynamic
histomorphometry to quantify the contribution of periosteal OCPs in adult bone formation in vivo. We also
generated a primary cilium knockout model and isolated periosteal cells to study the role of the cilium in
periosteal OCP mechanosensing in vitro. Experimental groups were compared using one-way analysis of
variance or student’s t test, and sample size was determined to achieve a minimum power of 80%.
Results: Mice without periosteal OCPs had severely attenuated mechanically induced bone formation and
lacked the mineralization necessary for daily skeletal maintenance. Our in vitro results demonstrate that OCPs
in the periosteum uniquely sense fluid shear and exhibit changes in osteogenic markers consistent with
osteoblast differentiation; however, this response is essentially lost when the primary cilium is absent.
Conclusions: Combined, our data show that periosteal progenitors are a mechanosensitive cell source that
significantly contribute to adult skeletal maintenance. More importantly, an OCP population persists in the
adult skeleton and these cells, as well as their cilia, are promising targets for bone regeneration strategies.
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Background
Bone is a dynamic, self-repairing tissue, and its adapta-
tion is of interest for developing regenerative therapeu-
tics. One commonly studied natural phenomenon is
adult bone formation, whereby the mature skeleton gen-
erates more bone in response to heightened physical
forces. The leading paradigm is that mechanosensitive
osteocytes sense mechanical loading and secrete para-
crine factors to recruit osteogenic precursors for new
bone formation [1]. Conversely, a lack of physical load-
ing causes osteocytes to trigger osteoclastic bone resorp-
tion, adapting the skeleton to reduce weight and
metabolic demands while maintaining sufficient strength
to withstand the reduced loads. Treatments that prevent
resorption to combat bone loss have been associated
with atypical fracture [2, 3]. Thus, the focus has shifted
towards strategies favoring bone anabolism. Investigating
adaptation to increased loading provides insights into
the recruitment of osteogenic precursors, as well as acti-
vation of osteoblasts to deposit new bone matrix. Ideal
regenerative techniques to generate bone where it is
needed would combine an effective osteoprogenitor cell
source with agents to enhance cell-mediated mineral ap-
position. As a result, determining the origin of osteo-
genic precursors and elucidating the mechanisms that
trigger osteoblast activity will significantly benefit emer-
ging therapeutics.
The periosteum, a thin coating surrounding the bone,
has recently re-emerged as an attractive source of osteo-
genic progenitor cells. This tissue can be isolated from
several locations in the body, such as the anterior tibia
and the spinous process. Periosteum is easier to extract
than bone marrow mesenchymal stem cells (MSCs), and
its inner cambium layer is rich in progenitors believed to
differentiate into bone-forming osteoblasts [4–6]. Fur-
thermore, load-induced bone formation is favored over
resorption at the periosteal surface, suggesting periosteal
progenitors are biased towards osteogenesis [7]. In gen-
eral, mechanical stimulation is thought to elicit an osteo-
genic response from progenitor cells [8, 9] and, indeed,
osteogenic markers are upregulated in mechanically
strained periosteal cells [10]. Despite the mounting evi-
dence suggesting osteoblasts arise from the periosteum
during bone formation, the exact mechanism for how
periosteal cells respond to heightened loads remains
unknown.
A subset of cells in the postnatal periosteum express
Paired related homeobox 1 (Prx1) and preferentially differ-
entiate towards an osteogenic or chondrogenic lineage in
vitro [11]. These osteochondroprogenitor cells (OCPs)
profoundly contribute to adult fracture repair [11, 12], but
their role in daily skeletal maintenance and adult bone for-
mation remains unexplored. Prx1 is expressed throughout
the mesenchymal limb bud, and the Prx1Cre transgene is
believed to label multipotent mesenchymal progenitors
during skeletal development [13]. Studies using constitu-
tive Prx1-driven Cre expression identified recombined os-
teoblasts, osteocytes, adipocytes, perivascular stromal
cells, and progenitor cells in many tissues, including the
periosteum and bone marrow [11, 14–16]. However, the
creators of an inducible Prx1CreER model suggest Prx1
expression is perhaps more restricted than previously re-
ported and may be useful for studying periosteal OCPs
[11]. Our previous work with this inducible model indi-
cates the Prx1Cre transgene is present in the periosteum
of skeletally mature mice, but Prx1 expression patterns in
the adult remain largely uncharacterized.
One possible mechanism for how periosteal OCPs sense
mechanical loading is that they directly sense physical
stimulation through their primary cilia, sensory organelles
known to transduce external stimuli into intracellular sig-
naling cascades. The primary cilium is present on all bone
cells and is important for cell differentiation. Specifically,
previous in vitro studies in our laboratory suggest cilia are
necessary for osteogenic differentiation of periosteal pro-
genitors [4, 9] and human MSCs [8, 17]. Eliminating key
ciliary proteins results in attenuated bone formation in vivo
[18–20]. Furthermore, we recently determined that mech-
anical loading activates progenitors to form bone in adults,
but this response is attenuated in mice containing a
Prx1-driven cilium knockout (Chen et al., manuscript sub-
mitted). Despite the clear implications, the mechanism that
allows periosteal OCP primary cilia to mediate the response
to mechanical stimulation has yet to be investigated.
Periosteal OCPs may also differentiate in response to
paracrine signals from mechanically stimulated osteo-
cytes. In response to loading, osteocytes are thought to
signal to osteoblasts and osteogenic precursors, trigger-
ing progenitor differentiation, osteoblast proliferation,
and, ultimately, matrix deposition. Our laboratory and
others have demonstrated that conditioned media from
osteocytes exposed to fluid shear triggers osteoblast ac-
tivity [21] and induces osteogenic differentiation of
MSCs [8]. In fact, conditioned media from osteocytes in
a static environment alone has been shown to encourage
osteogenic differentiation of bone marrow stromal cells
[22]. Osteoblasts respond directly to mechanical stimula-
tion [23], as well as paracrine signaling from osteocytes
[1, 21], but it is unknown whether periosteal OCPs be-
have similarly. Furthermore, our conditioned media
study indicates that the primary cilium is necessary for
paracrine signaling between osteocytes and MSCs [8]. If
periosteal OCPs do respond to osteocyte signaling, it will
be important to know whether this process is mediated
by the primary cilium.
The objectives of this study are four-fold. First, to de-
termine Prx1 expression in the skeletally mature adult
mouse ulna using a fluorescent reporter model. Spatially
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mapping the presence of the Prx1Cre-GFP transgene is
critical for characterizing the affected cell population in
our model. Second, to quantify the contribution of
Prx1-expressing cells in load-induced bone formation
using a conditional diphtheria toxin A (DTA) cell abla-
tion model. Third, to identify whether periosteal cells
respond to mechanical stimulation and/or paracrine sig-
naling from osteocytes in vitro. Finally, we seek to deter-
mine the mechanism by which primary cilia potentially
mediate the periosteal OCP response to mechanical
loading through in vitro fluid-shear studies.
Methods
Animal models
All mouse models are based on a C57BL6 background.
Prx1CreER-GFP males were bred with Rosa26tdTomato fe-
males acquired from Jackson Laboratories (Bar Harbor,
ME) to generate a Prx1CreER-GFP;Rosa26tdTomato(−/+)
fluorescent reporter model. Prx1CreER-GFP females were
bred with Rosa26DTA males acquired from Jackson La-
boratories to generate Prx1CreER-GFP;Rosa26DTA(−/+) ex-
perimental and Rosa26DTA(−/+) control offspring. Animals
used for the ulnar loading experiments did not participate
in breeding. Prx1CreER-GFP and Prx1CreER-GFP;Ift88fl/+
males were bred with Ift88fl/fl females to generate
Prx1CreER-GFP;Ift88fl/fl offspring for primary periosteal
cell isolations. Genotype was determined using polymer-
ase chain reaction (PCR) and agarose gel electrophoresis.
Primer sequences are available upon request. Animals
were housed, maintained, and evaluated for health compli-
cations in accordance with IACUC standards. All experi-
ments were approved by the Institute of Comparative
Medicine at Columbia University.
Tamoxifen injections
Tamoxifen (Sigma-Aldrich, St. Louis, MO) was
dissolved in corn oil (Sigma-Aldrich) in a shaking
incubator at 37 °C to create a 25 mg/mL stock
solution stored at 4 °C and protected from light.
Fresh tamoxifen solution containing 10% ethanol was
prepared daily and delivered via injection to ensure
consistent exposure. Skeletally mature 16-week-old
adult Prx1CreER-GFP;Rosa26tdTomato mice received a
single intraperitoneal injection of 100 mg/kg body
weight tamoxifen. Adult Prx1CreER-GFP;Rosa26DTA
experimental and Rosa26DTA controls received daily
intraperitoneal injections of 75 mg/kg tamoxifen
solution for 5 days prior to loading, concurrent with
the 3 days of loading, and concurrent with fluorochrome
label injections after loading. Injections were performed at
the same time each morning in a clean cage placed in a
laminar flow hood.
In vivo ulnar loading
Skeletally mature 16-week-old mice were placed under
isofluorane anesthesia and the right forelimbs were an-
chored between two plates attached to an electromag-
netic Enduratec ELF 3220 loading system with feedback
control (Bose, Framingham, MA). Following an initial
0.1 N load, a peak compressive axial load of 3 N was ap-
plied with a 2 Hz sine wave for 120 cycles/day for 3 con-
secutive days. The nonloaded left forelimbs served as
internal controls. Body weight was measured each time
an injection or ulnar loading was administered, and cage
activity and anesthesia recovery time were observed to
monitor animal health. Mice received subcutaneous in-
jections of 10 mg/kg calcein (Sigma-Aldrich) and 70 mg/
kg alizarin red (Sigma-Aldrich) 5 and 9 days following
initiation of loading, respectively. All animals were
euthanized 15 days after the initiation of loading and
prepared for analysis.
Microcomputed tomography (microCT) and dynamic
histomorphometric analysis
Upon sacrifice, loaded and nonloaded ulnae were dis-
sected and stored in 70% ethanol for up to a week. The
nonloaded limb of each specimen was imaged by
microCT (Scanco vivaCT 80, Scanco Medical AG, Brüt-
tisellen, Switzerland) at 10.4 μm isotropic resolution
using scan settings of 55 kV, 145 μA, and 300 ms inte-
gration time. Bone lengths were determined from the
scout view. Cortical bone analyses were performed at
the mid-diaphysis of each ulna and Scanco analysis soft-
ware was used to determine total bone area, the ratio of
bone volume to total volume (BV/TV), bone mineral
density (BMD), cortical thickness, the polar moment of
inertia (J), and the minimum and maximum second mo-
ments of inertia (Imin and Imax).
Following the microCT scan, ulnae were gradually
dehydrated in an ASP300S tissue processor (Leica, Wet-
zlar, Germany), infiltrated with methyl methacrylate, and
embedded in methyl methacrylate and benzoyl peroxide
(Sigma-Aldrich), as described previously [18]. Embedded
specimens were sectioned at the ulnar midshaft using a
diamond-tip blade and saw (Isomet, North Springfield,
VA) and transverse sections were imaged on a Fluoview
confocal microscope (Olympus, Shinjuku, Tokyo, Japan).
The bone surface, single label, and double label perime-
ters and double label area were quantified in ImageJ
(Broken Symmetry Software) to calculate mineralizing
surface/bone surface (MS/BS), mineral apposition rate
(MAR), and bone formation rate/bone surface (BFR/BS)
[18, 24]. All measurements were taken from the perios-
teal surface. Nonloaded ulnae values were subtracted
from loaded values to determine relative measurements
of rMS/BS, rMAR, and rBFR/BS, which represent
changes specifically due to mechanical loading.
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Histology and immunocytochemistry
Upon sacrifice, ulnae were dissected and fixed overnight
at 4 °C. For histological analysis, specimens were fixed in
10% formalin (Sigma-Aldrich), decalcified, embedded in
paraffin, sectioned longitudinally in 5μm increments, and
stained with hematoxylin and eosin (H&E) (Sigma-Al-
drich) for 10 min and 30 s, respectively. Micrographs were
collected with a CKX41 inverted microscope (Olympus)
at 20× magnification. To determine whether our ablation
model was successful in inducing cell death, ulnae were
fixed in 4% paraformaldehyde (Sigma-Aldrich), decalcified,
and cryosectioned longitudinally in 5μm increments. GFP
was visualized and micrographs were collected with a con-
focal microscope (Olympus) at 100× magnification.
To detect primary cilia in vitro, isolated and sorted
primary periosteal OCPs were seeded on glass bottom
dishes (MatTek, Ashland, MA) at 2.5 k per dish 24 h
prior to experimentation. Following treatment, cells were
fixed in 10% formalin, blocked with 15% goat serum,
and incubated in a primary antibody for acetylated
α-tubulin acquired from a C3B9 hybridoma line
(Sigma-Aldrich), followed by a fluorescent secondary
(1:500, Alexa-Fluor 488, Life Technologies). All incuba-
tions were conducted at room temperature for 1 h.
Micrographs were collected with a confocal microscope
(Olympus) at 100X magnification.
Primary cell isolation
Prx1CreER-GFP and Prx1CreER-GFP;Ift88fl/fl juveniles
were sacrificed between 3 and 4 weeks of age and their
fore- and hindlimbs were dissected. The skin, fascia,
connective tissue, and majority of the muscle surround-
ing the periosteum was removed using a scalpel and the
specimens were placed in sterile phosphate-buffered sa-
line (PBS; Life Technologies, Carlsbad, CA) on ice. The
epiphyses and remaining muscle surrounding the perios-
teum were removed, and the specimens were transferred
to fresh cold PBS. In a sterile culture hood, the perios-
teum was scored with a scalpel, peeled off the bone, cut
into 1mm2 sections, and placed into fibronectin-coated
(Sigma-Aldrich) tissue culture dishes containing mini-
mum essential medium (MEM)α (Life Technologies)
supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin (P/S; Life Technologies). Tis-
sue sections were incubated at 37 °C for 7–10 days and
the resulting primary periosteal cells were passaged onto
fresh fibronectin-coated tissue culture dishes. Cells were
then passaged or sorted upon reaching 80% confluence.
Cell culture and sorting
Primary periosteal cells were cultured on fibronectin-
coated dishes in MEMα supplemented with 10% FBS
and 1% P/S at 37 °C. An Influx cell sorter (BD
Biosciences, San Jose, CA) was used to separate
osteochondroprogenitors (GFP+) from other cells of the
periosteum (GFP–). Sorted cells were cultured for 1–
2 weeks until a sufficient number were available for flow
studies. Passages P2 to P5 were used for all in-vitro ex-
periments. MLO-Y4 osteocytes were cultured on colla-
gen type I-coated tissue culture dishes (Corning Inc.,
Corning, NY) in MEMα supplemented with 5% FBS, 5%
calf serum (CS), and 1% P/S at 37 °C. P40 to P45 were
used for conditioned media studies.
In-vitro fluid-flow studies
To test the effects of direct mechanical stimulation on
periosteal cells, osteochondroprogenitors (GFP+) and
other cells of the periosteum (GFP–) were seeded on
fibronectin-coated glass slides (75 × 38 × 1 mm; Fisher Sci-
entific, Hampton, NH) and cultured in reduced serum
media (MEMα supplemented with 2.5% FBS, 2.5% CS,
and 0.5% P/S) 48 h prior to application of flow. To disrupt
primary cilia, cells were treated with the active metabolite
of tamoxifen, (Z)-4-hydroxytamoxifen (Sigma-Aldrich), di-
luted to 5 μg/mL in 95% ethanol or vehicle control 24 h
prior to flow. Upon reaching 80% confluence, primary
cells were placed in parallel-plate flow chambers (56 ×
24 × 0.28 mm), incubated at 37 °C for 30 min at rest, and
exposed to 60 min of oscillatory fluid flow (OFF) at 1 Hz
with a peak shear stress of 10 dyn/cm2. Slides were re-
moved from the chambers and lysed immediately with
TriReagent (Sigma-Aldrich) to isolate RNA. Real-time
quantitative PCR (RT-qPCR) was performed to quantify
flow-induced changes in Cyclooxygenase-2 (COX-2),
Osteopontin (OPN), Runt-related transcription factor 2
(RUNX2), Bone gamma-carboxyglutamic acid-containing
protein (BGLAP), and Glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) using fluorescent primers (Life
Technologies) and an ABI PRISM 7900 (Applied Biosys-
tems, Foster City, CA). Samples were performed in tripli-
cate and normalized to the expression of GAPDH, a
housekeeping gene. OFF samples were normalized to
static controls.
For conditioned media studies, MLO-Y4 osteocytes
were seeded on four-well plates (Fisher Scientific,
127.8 × 85.5 mm) at 75k cells per well and cultured for
approximately 2 days until cells were 80% confluent. Iso-
lated primary Prx1CreER-GFP;Ift88fl/fl periosteal OCPs
were seeded on four-well dishes at 100k per well and
treated with (Z)-4-hydroxytamoxifen or vehicle control
for 24 h prior to receiving conditioned media. Fresh
media (3.5 mL) was placed on MLO-Y4s immediately
before being exposed to OFF (0.78 dyn/cm2, 0.33 Hz) on
a platform rocker [8] or static conditions at 37 °C for
12 h. At the conclusion of flow, media were aspirated
from MLO-Y4s and centrifuged at 2 rpm for 10 min to
prevent contamination by detached MLO-Y4s; 2 mL of
centrifuged media was transferred to each well of the
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primary periosteal cells, which were cultured for 48 h
and lysed for RT-qPCR as described previously.
Statistics
Animals were randomly assigned to groups depending
on genotype, and researchers were blinded to all data
analysis. No sex-dependent differences were identified
according to a two-way analysis of variance (ANOVA),
and so males and females were grouped together for dy-
namic histomorphometry and microCT analysis. We
could not assume normality for our in vivo data and so
comparisons were determined with a one-way ANOVA
and Bonferroni post-hoc correction. Our in vitro data
satisfied conditions of normality and so we analyzed
comparisons using a two-tailed student’s t test. Values
are reported as mean ± SEM, with p < 0.05 considered
statistically significant. The sample size was selected to
achieve a power of at least 80% for all tests.
Results
Prx1 expression is restricted to the periosteum in ulnae of
skeletally mature adults
Skeletally mature 16-week-old fluorescent reporter mice
(Prx1CreER-GFP;Rosa26tdTomato) were injected with a
single dose of tamoxifen to determine the location of
Prx1-expressing cells and confirm Cre activity. Red
fluorescent cells were indeed present, indicating success-
ful Cre recombination. We found recombined cells in
the ulnar periosteum (Fig. 1) and perichondrium (not
shown), but these cells were absent from cortical bone,
trabecular bone, muscle, and marrow. Therefore, it can
be concluded that the Prx1CreER-GFP model is an ap-
propriate tool for determining the effects of periosteal
OCP ablation on load-induced adult bone formation.
Tamoxifen treatment successfully ablates periosteal
progenitors in vivo and primary cilia in vitro
We generated inducible ablation and primary cilium
knockout (KO) models to evaluate the effects of eliminat-
ing OCPs and their primary cilia. Animals did not exhibit
any noticeable adverse effects from tamoxifen injection or
OCP ablation. We visualized GFP expression to determine
whether Prx1-expressing OCPs were present in the peri-
osteal tissue of Prx1CreER-GFP;Rosa26DTA mutant and
Prx1CreER-GFP control adult mice injected with tamoxi-
fen. Control animal periosteum contained green fluores-
cent cells but these were absent from mutant periosteum
(Fig. 2), indicating successful ablation of periosteal OCPs
in vivo. We then determined whether tamoxifen treatment
could be used to disrupt periosteal OCP cilia in vitro. Pri-
mary OCPs isolated from the periosteum of
Prx1CreER-GFP;Ift88fl/fl juveniles were sorted via GFP
and treated with 4-hydroxytamoxifen, the active me-
tabolite of tamoxifen, to induce an Ift88-mediated
primary cilium knockout. Indeed, cells treated with
4-hydroxytamoxifen had nearly half the Ift88 mRNA
expression observed in vehicle controls (Fig. 2). Fur-
thermore, these cells demonstrated shorter and fewer
cilia compared with vehicle controls (Fig. 2), confirm-
ing that this treatment successfully disrupted primary
cilia in vitro.
Bone formation is severely attenuated in mice lacking
periosteal progenitors
Genetic modifications may alter bone structure in trans-
genic animals, resulting in changes that influence the skel-
eton’s response to load. To ensure that our ablation model
did not alter bone properties and introduce a confounding
variable in our loading studies, we first assessed bone
microstructure in our Prx1CreER-GFP;Rosa26DTA and
Rosa26DTA animals using microCT. We did not identify
any differences in bone microstructure (Table 1); there-
fore, our dynamic histomorphometry results depict
changes in bone formation specifically due to periosteal
OCP ablation prior to loading.
We then exposed skeletally mature adult mice to com-
pressive axial ulnar loading and visualized fluorochrome
labels approximately 2 weeks following loading to assess
mineralization with standard cage activity and in re-
sponse to load. Control animals demonstrated some
mineralization in the nonloaded limb and, as expected,
the mineralizing surface was greater in response to load
(Fig. 3). We also observed a distinct gap between the ali-
zarin and calcein labels in loaded control animals, indi-
cating newly formed bone. In contrast, ablation animals
demonstrated very little mineralizing surface under
Fig. 1 Prx1 expression is confined to the adult periosteum in the ulnar
midshaft. Skeletally mature 16-week-old Prx1CreER-GFP;Rosa26tdTomato
mice received a single dose of tamoxifen to induce tdTomato
production and were sacrificed a week later. Recombined cells
(red) were found in the periosteum (white arrows) of the ulna,
but were absent from cortical bone, trabecular bone, muscle,
and bone marrow. Micrographs were captured with a confocal
microscope at 20X. Scale bar = 50 μm
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nonloaded conditions and a weak increase in response
to load, suggesting very little bone was formed under
static and loaded conditions. We quantified our observa-
tions via dynamic histomorphometry and, indeed, mu-
tants lacking OCPs have a smaller mineralizing surface
(Fig. 3b) and decreased mineral apposition rate (Fig. 3c).
Consequently, mice lacking OCPs have a severely atten-
uated bone formation rate (Fig. 3d).
We then performed H&E stains to visualize any poten-
tial abnormalities in bone tissue in the loaded ulna of
Fig. 2 Tamoxifen treatment successfully ablates periosteal progenitors and their cilia in our transgenic animal models. Skeletally mature 16-week-old
Prx1CreER-GFP;Rosa26DTA ablation mice and Prx1CreER-GFP controls received tamoxifen injections and were sacrificed a week later. Prx1-expressing
cells (green) were observed in the periosteum of Prx1CreER-GFP control ulnae (a) but were absent in Prx1CreER-GFP;Rosa26DTA animals (b). Primary
OCPs obtained from 3-week-old Prx1CreER-GFP;Ift88fl/fl animals (c) normally contain primary cilia (red); however, the presence and length of these cilia
was diminished after exposure to 5 μM 4-hydroxytamoxifen (d). Indeed, cells treated with tamoxifen have decreased Ift88 mRNA expression (e). A
magnified view of box region in panels c and d (f). Micrographs of the periosteum and isolated cells were collected at 20X and 40X, respectively.
Nuclei are displayed in blue. Scale bars = 50 μm. Data are reported as mean and standard error. n = 4 for each group, ***p < 0.0001
Table 1 Ulna cortical bone microarchitecture
Parameter Female Male
Control Ablation Control Ablation
n 5 5 8 5
Bone area (mm2) 0.281 ± 0.012 0.263 ± 0.018 0.294 ± 0.005 0.295 ± 0.006
Cortical thickness (mm) 0.172 ± 0.001 0.169 ± 0.004 0.169 ± 0.004 0.175 ± 0.002
BV/TV (%) 0.867 ± 0.002 0.864 ± 0.003 0.863 ± 0.002 0.863 ± 0.001
BMD (mg/cm3 of HA) 1293 ± 5.3 1289 ± 5.2 1282 ± 3.3 1288 ± 7.0
J (mm4) 0.024 ± 0.003 0.020 ± 0.003 0.027 ± 0.001 0.027 ± 0.001
Imax (mm
4) 0.019 ± 0.003 0.016 ± 0.003 0.022 ± 0.001 0.023 ± 0.001
Imin (mm
4) 0.0043 ± 0.0004 0.0040 ± 0.0005 0.0048 ± 0.0004 0.0040 ± 0.0002
Data are presented as the mean ± standard error
BMD bone mineral density, BV/TV ratio of bone volume to total volume, HA hydroxyapatite, J inertia, Imax maximum second moment of inertia, Imin minimum
second moment of inertia
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animals with and without periosteal OCPs
(Additional file 1: Figure S1). Surprisingly, the peri-
osteum was consistently thinner in ablated animals,
perhaps due to loss of OCPs in the cambium layer.
We initially noticed this trend when we confirmed
the ablation model and noted that the periosteum
appeared thinner when GFP+ cells were absent (Fig.
2b). We speculated that atypical woven bone may
have formed in mutants, but histology revealed that
both groups generated normal lamellar bone in
response to load. Interestingly, we identified perios-
teal cells differentiating into osteoblasts to lay down
new matrix in response to load in control animals,
but this behavior was lost entirely in the ablation
animals.
Primary periosteal progenitors have an osteogenic
response to mechanical stimulation
Although periosteal tissue [25] and calvaria periosteal
osteoprogenitors [26] respond to physical stimulation, it
is unknown whether OCPs in long bone periosteal tissue
are mechanoresponsive. We therefore isolated cells from
murine tibial periosteum and exposed them to oscilla-
tory fluid flow (OFF) to determine if these cells respond
to mechanical stimulation. Furthermore, we separated
periosteal Prx1-expressing OCPs from the other cells of
the periosteum to evaluate whether this population has a
greater osteogenic response to physical stimuli. Indeed,
sorted periosteal OCPs exposed to OFF exhibited in-
creased COX-2 mRNA production compared with static
controls (Fig. 4a), indicating a cellular reaction to
Fig. 3 Mineralization and load-induced bone formation are severely attenuated in mice lacking OCPs. Skeletally mature Rosa26DTA control and
Prx1CreER-GFP;Rosa26DTA ablation animals injected with tamoxifen were exposed to ulnar loading and the resulting mineralizing surfaces were
labeled with calcein (green) and alizarin (red) fluorochrome dyes. Mice lacking periosteal OCPs demonstrated poor mineralization, indicated by a
lack of labeling at the periosteal surface in both loaded and nonloaded ulnae (a). We performed dynamic histomorphometry and confirmed this
visual observation (b). Ablated animals also exhibited an inferior mineral apposition rate (c), resulting in attenuated bone formation compared
with controls (d). Loaded ulnae were normalized to nonloaded contralateral limbs. Micrographs were collected at 10X. Data are reported as mean
and standard error. n = 16 for each group, ***p < 0.0001. rBFR/BS relative bone formation rate/bone surface, rMAR relative mineral apposition rate,
rMS/BS relative mineralizing surface/bone surface
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physical stimulation. OCPs also demonstrated a
flow-induced increase in OPN, which indicates an osteo-
genic response to fluid flow (Fig. 4b). The OCP response
to flow is unique since other cells of the periosteum
demonstrated no change in COX-2 or OPN expression
(Fig. 4a, b). Interestingly, Prx1-expressing OCPs had sig-
nificantly higher levels of OPN mRNA under static con-
ditions than other cells of the periosteum in static (p <
0.05) or flow conditions (Fig. 4b). Periosteal OCPs also
exhibited significantly greater fold changes in COX-2
and OPN expression compared with other cells of the
periosteum (Fig. 4c, d), indicating that OCPs are drastic-
ally more responsive to mechanical stimulation. Collect-
ively, these data suggest periosteal OCPs directly sense
mechanical loading and respond in a pro-osteogenic
manner.
Primary cilia are necessary for the osteogenic response to
physical stimulation
We then examined whether this osteogenic response to
flow was mediated by the primary cilium. Primary peri-
osteal OCPs were isolated from Prx1CreER-GFP;Ift88fl/fl
animals and treated with a vehicle control or the active
metabolite of tamoxifen to induce a primary cilium
knockout. We evaluated mRNA expression levels of
COX-2, which indicates a cellular response to physical
stimulation, and OPN, RUNX2, and BGLAP, which
are markers for osteogenesis. OCPs with intact cilia
demonstrated increased COX-2 (p < 0.001), OPN
(p < 0.05), and RUNX2 (p < 0.001), but decreased
BGLAP (p < 0.05) expression in response to flow.
These flow-induced changes in mRNA expression
were absent in KO cells, indicating an abrogated
Fig. 4 Periosteal OCPs uniquely respond to mechanical stimulation in an osteogenic manner. Primary periosteal cells isolated from 3-week-old
Prx1CreER-GFP mice were exposed to 1 h of oscillatory fluid flow (OFF) and changes in mRNA expression were quantified via RT-qPCR. Prx1-expressing
OCPs (green) exposed to OFF (line pattern) demonstrated increases in Cyclooxygenase-2 (COX-2) (a) and Osteopontin (OPN) expression (b) compared
with controls, whereas other cells of the periosteum (white) were nonresponsive. OCPs have elevated OPN expression compared with other cells of
the periosteum under static conditions (b). Additionally, the fold changes in COX-2 (c) and OPN (d) expression were significantly higher for OCPs
compared with other cells of the periosteum. mRNA expression was normalized to GAPDH expression. Data are reported as mean and standard error.
Other no-flow n = 5, other flow n = 7, OCP no-flow and flow n = 6, *p < 0.01, ***p < 0.0001
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response to OFF (Fig. 5). This suggests that primary cilia
are necessary for periosteal OCPs to 1) sense mechanical
stimulation and 2) respond to fluid shear in an osteogenic
fashion.
Periosteal progenitors also respond to paracrine signals
from stimulated osteocytes through a cilium-mediated
mechanism
Thus far, we have shown that bone-forming osteoblasts
arise from periosteal OCPs in response to physical
stimulation. Another mechanism by which cells may dif-
ferentiate into osteoblasts is through paracrine signaling
from mechanically stimulated osteocytes [8]. We ex-
plored this possibility through a conditioned media
study. MLO-Y4 osteocyte-like cells were exposed to OFF
and the resulting media was transferred onto periosteal
OCPs with and without primary cilia. Indeed, OCPs with
intact cilia demonstrated an increase in mRNA expres-
sion of the osteogenic markers OPN (p < 0.05), RUNX2
(p < 0.05), and BGLAP (p < 0.01). Again, the fold changes
in mRNA expression were lost with cilium disruption
(Fig. 6), indicating a loss of paracrine signaling.
Discussion
Despite its ubiquity in embryonic development, Prx1 ex-
pression is restricted to the periosteum in the adult ulna.
Prx1 expression is rampant in the mesenchymal limb
bud but it has been incompletely characterized after
birth [11]. Previous studies report labeled cells in a wide
variety of tissues, suggesting the Prx1Cre transgene de-
notes a multipotent mesenchymal progenitor population
[14]. However, these experiments utilize constitutively
active models which label cells that have expressed Prx1
at any point in time, including embryonic development.
Prx1-expressing cells and their progeny populate a vast
array of tissues during development, so it is perhaps not
surprising that the authors identified labeled cells
throughout the adult skeleton. These constitutive
Fig. 5 OCP primary cilia are necessary for the flow-induced osteogenic response. Primary periosteal OCPs isolated from 3-week-old Prx1CreER-
GFP;Ift88fl/fl mice were treated with the active compound of tamoxifen or vehicle control and exposed to 1 h of oscillatory fluid flow (OFF).
Vehicle control OCPs (white) demonstrated an increase in Cyclooxygenase-2 (COX-2) (a), Osteopontin (OPN) (b), and Runt-related transcription
factor 2 (RUNX2) (c) expression, but a decrease in Bone gamma-carboxyglutamic acid-containing protein (BGLAP) (d) expression. These effects
were lost in OCPs treated with tamoxifen (gray) to disrupt ciliogenesis. mRNA expression was normalized to GAPDH expression and OFF samples
were normalized to static controls. Data are reported as mean and standard error. Vehicle n = 6, tamoxifen n = 5, ***p < 0.0001
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models therefore successfully track Prx1-expressing cells
and their progeny, but do not outline specific Prx1 ex-
pression patterns in the adult skeleton. Kawanami et al.
[11] developed a tamoxifen-inducible model containing
Prx1-driven GFP expression and suggested that Prx1 ex-
pression is perhaps more confined in the limb after
birth. We crossed this inducible model with a red fluor-
escent reporter and visualized GFP and tdTomato in our
Prx1CreER-GFP;Rosa26tdTomato model to more accur-
ately identify cells that express Prx1 in the forelimbs of
skeletally mature adults. The vast majority of labeled
cells were found in the periosteum, with some present in
the perichondrium and shoulder tendon, but were ab-
sent from bone marrow, muscle, and bone. The peri-
chondrial expression may be unique to mice since their
epiphyseal growth plates do not close [27] like those in
other animals. Due to physical distance alone, it is highly
unlikely that cells from the perichondrium or shoulder
tendon would contribute to bone formation in the mid-
shaft of the diaphysis. Prx1-expressing cells isolated from
periosteal tissue demonstrate an osteochondrogenic na-
ture in vitro [11]; therefore, we are confident that our
Prx1 model is an excellent tool for evaluating the role of
periosteal OCPs in load-induced bone formation. This is
in agreement with a recent fracture study concluding
that the Prx1 model was appropriate for studying a
unique population of self-regenerating periosteal cells in
older mice [12].
Prx1-expressing periosteal OCPs are known to domin-
ate fracture repair but our results demonstrate they also
contribute to adult bone formation to a great degree.
Skeletal trauma elicits a response from many cell types,
Fig. 6 OCPs require primary cilia to respond to paracrine signals from mechanically stimulated osteocytes. Primary periosteal OCPs isolated from
3-week-old Prx1CreER-GFP;Ift88fl/fl mice were treated with the active compound of tamoxifen to disrupt ciliogenesis or vehicle control and then
treated with conditioned media from MLO-Y4s exposed to oscillatory fluid flow (OFF) or static controls. Vehicle control OCPs (white) demonstrated a
nearly twofold increase in Osteopontin (OPN) (a), Runt-related transcription factor 2 (RUNX2) (b), and Bone gamma-carboxyglutamic acid-containing
protein (BGLAP) expression (c). This effect was lost in OCPs treated with tamoxifen (gray). mRNA expression was normalized to GAPDH expression and
OFF samples were normalized to static controls. Data are reported as mean and standard error. n = 5 for both groups, ***p < 0.0001
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so it is perhaps not surprising that Prx1-expressing cells
participate in fracture repair. Load-induced bone forma-
tion is a relatively milder response to a less intense ex-
ternal stimulus and involves differentiation of osteogenic
precursors to form new bone via intramembranous ossi-
fication. Our dynamic histomorphometry data indicate
that load-induced bone formation is almost entirely lost
when Prx1-expressing periosteal OCPs are absent. Al-
though this outcome is somewhat expected since cam-
bium layer progenitors are known to participate in
intramembranous ossification, these results are import-
ant for three reasons. First, our data contribute to
mounting evidence that Prx1-expressing cells play a crit-
ical role in adult skeletal maintenance. All mesenchymal
cells in the limb bud express Prx1 and therefore have
been heavily investigated in embryonic development, but
Prx1-expressing cells are largely unexplored in adult
skeletal phenomena. Our results, combined with studies
showing that Prx1-expressing cells populate the fracture
callus [11, 12, 28], indicate these OCPs continue to in-
fluence skeletal metabolism and morphology following
their well-documented initial role in embryonic skeletal
development. Second, the extreme impact of ablating
Prx1-expressing periosteal OCPs suggests these osteo-
genic precursors are perhaps the primary source of oste-
oblasts that form new bone in response to heightened
physical loads. This population has also been implicated
as the main cell source for the fracture callus [12, 29]
and overall appears to be a critical supply of osteogenic
precursors. Lastly, mutants still display some
mineralization, suggesting that Prx1-expressing cells are
not the only source of bone-forming osteoblasts. The
mineralization that does occur in mutants is potentially
from other osteogenic precursors in the periosteum or
bone lining cells, which line the periosteal surface and
are a continuous source of osteoblasts in mature bone
[30, 31]. Another possibility is that some OCPs remained
due to incomplete Cre recombination, but we found that
Prx1-expressing cells were totally ablated in vivo in our
model (Fig. 2b). Regardless of other cell involvement,
periosteal OCPs contribute to adult skeletal maintenance
to such a degree that they deserve more consideration
for adult bone tissue regeneration strategies.
For the first time, we have shown that periosteal OCPs
have an osteogenic response to direct physical stimula-
tion, as well as paracrine signals from mechanically stim-
ulated osteocytes. Furthermore, we identified that the
primary cilium is a major factor in periosteal OCPs sens-
ing stimulation and inducing osteogenesis. We previ-
ously identified that load-induced bone formation was
attenuated in animals containing a Prx1-driven condi-
tional primary cilium knockout (Chen et al., manuscript
submitted); however, the Prx1-expressing periosteal
OCP primary cilium’s exact role during bone formation
remained unclear. One possibility is that periosteal
OCPs directly sense mechanical stimulation via their pri-
mary cilia and consequently differentiate into
bone-forming osteoblasts. Indeed, we found that perios-
teal OCPs have an immediate osteogenic response to
fluid shear that is nearly abrogated when cilia are absent.
An earlier study utilized Northern blotting to determine
that OPN and BGLAP mRNA expression in rat tibia
periosteum is decreased 2 h after exposure to four-point
bending [32]. The authors also found increased expres-
sion of proliferation markers and, combined with the de-
crease in mRNAs encoding bone matrix proteins,
concluded that the initial periosteal response to load is
rapid proliferation. We also observe a decrease in
BGLAP, which suggests proliferation, but a contradictory
increase in OPN, which favors osteogenic differentiation.
However, we examined a specific OCP cell population
whereas the aforementioned authors quantified mRNA
expression in whole periosteal tissue. We speculate that
the Prx1-expressing population possesses unique osteo-
genic characteristics and may simultaneously proliferate
and differentiate. A second theory is that osteocytes,
which are known to detect mechanical loading and acti-
vate osteogenic precursors [8], signal to periosteal OCPs
through a primary cilium-mediated mechanism to en-
courage osteoblastic differentiation and subsequent bone
formation. Interestingly, periosteal OCPs treated with
conditioned media from mechanically stimulated osteo-
cytes demonstrate increased mRNA expression of osteo-
genic markers 48 h later. We suspect the increase in
BGLAP observed here (Fig. 6c), which is contradictory
to our OFF results (Fig. 5d), is due to a discrepancy in
the evaluated time points. For example, osteoblasts ex-
posed to fluid shear in vitro do not demonstrate an in-
crease in BGLAP expression until 2 h after exposure
[33]. Similarly, we did not find changes in COX-2 ex-
pression after 48 h since this is an immediate,
short-term response. We therefore propose that, during
load-induced bone formation, periosteal OCP primary
cilia directly sense loading and receive signals from
mechanically stimulated osteocytes. These stimuli then
induce mechanosensitive OCP differentiation into active
osteoblasts, as well as rapid proliferation of OCPs, which
later differentiate to form bone.
Although osteogenesis is severely attenuated in its ab-
sence, the primary cilium is not the only mechanism by
which OCPs sense and respond to stimulation. The cell
membrane alone is capable of transducing physical stim-
uli via mechanosensitive ion channels, cadherins, integ-
rins/ focal adhesions, purinergic receptors, and
connexins [34]. For example, TRPV4 is a calcium ion
channel found in the primary cilium and cell membrane
and is known to be important for osteocyte mechano-
transduction. We previously identified that disrupting
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TRPV4 attenuates flow-induced osteogenesis when the
cilium is intact [35], and so it is possible that TRPV4 in
the cell membrane responds to physical stimulation in-
dependent of the primary cilium. The primary cilium is
also not uniquely involved in paracrine signaling since a
variety of receptor/ligand interactions exist independ-
ently of the cilium. Paracrine signals from osteocytes are
known to influence osteogenic differentiation [36], but
specific pathways have yet to be characterized. One pos-
sibility is that IGF, which is secreted by osteocytes, en-
courages OCP differentiation [37, 38]. Additionally, FGF,
Wnt, Hedgehog, and TGFβ/BMP signaling pathways in-
volve receptor/ligand interactions and are strong candi-
dates for OCP differentiation. Interestingly, the primary
cilium is associated with these pathways [39], and so we
speculate that the cilium mediates receptor/ligand inter-
actions to some degree. More work is required to fully
understand osteocyte-OCP signaling, but we hypothesize
that the primary cilium works in concert with other re-
ceptor/ligand interactions at the cell surface to generate
a complete response. For these reasons, osteogenesis is
not completely lost with primary cilium deletion in our
fluid shear and conditioned media in-vitro studies. How-
ever, the drastic attenuation we observe does suggest the
primary cilium plays a predominant role.
Load-induced bone formation decreases as mice age,
despite evidence suggesting that periosteal OCPs main-
tain function independently of age. In young adult mice,
periosteal progenitors are the main contributor to frac-
ture callus formation [28] and our data suggest they also
play a significant role in adult bone formation. Although
16-week-old mice contain a wealth of periosteal progeni-
tors, it is believed that older mice possess markedly
fewer periosteal cells and, consequently, have attenuated
load-induced bone formation. One study found that
19-month-old mice had significantly fewer periosteal
cells in response to loading compared with younger
16-week-old mice, resulting in severely limited bone for-
mation [40]. Interestingly, the initial number of perios-
teal cells prior to loading was similar between the
groups, suggesting a lack of proliferation and differenti-
ation in older mice. In another study, 54-week-old mice
displayed inferior fracture repair compared with
8-week-old mice, but repair was enhanced in both
groups when PTH 1–34 was intermittently administered
[41]. The authors therefore concluded that younger peri-
osteal cells are able to produce more matrix and differ-
entiate more rapidly. However, other studies indicate
that periosteal progenitors consistently proliferate and
function independent of age [42–44]. In fact, a recent
study demonstrated that Prx1-expressing periosteal cells
repopulate the periosteum after fracture and continue to
be the dominant cell type in the fracture callus in adult
mice, even after multiple fractures are initiated [12].
Since the periosteum contains a variety of cells, one pos-
sibility is that the number of OCPs decreases with age,
while the total number of periosteal cells remains com-
parable. Bone marrow stromal cells from young and old
human donors form similar amounts of mineralized
matrix in vitro and bone in vivo, indicating that cell
function remains intact with age [45]. This further sup-
ports the idea that decreased bone formation in older
age is a consequence of decreased proliferation and
fewer active osteoblasts. More importantly, it suggests
that progenitors, regardless of age, may be expanded
in vitro to provide a sufficient number of cells for tissue
regeneration. Another explanation for decreased bone
formation with age is a reduction in sensitivity to mech-
anical stimulation [46, 47]. Studies indicate older mice
and rats are unresponsive to low strains that successfully
trigger apposition in young mice [46, 48, 49], and one
group suggests bone formation and resorption, as dic-
tated by strain, becomes dysregulated [49]. However, it is
unclear whether the decreased sensitivity results from
changes at the tissue, cellular, and/or molecular levels.
Overall, the mounting evidence indicates that strategies
to produce bone at any age will need to generate a suffi-
cient number of OCPs and/or enhance OCP function.
Primary OCPs were easily extracted from periosteal
tissue and expanded in culture for our in-vitro experi-
ments, suggesting they are an attractive source for tissue
regeneration strategies. A typical isolation was per-
formed with 6–8 juvenile mice and periosteal tissue was
extracted from only the ulna and tibia. Cells adhered to
the dish surface within 3–5 days and continued to mi-
grate from tissue for as long as 2 weeks after the dissec-
tion. Within 3 weeks of the initial dissection,
approximately 8 million cells were available for sorting.
Interestingly, only 3.3 ± 0.8% (n = 10 sorts) of the 8 mil-
lion cells were GFP+ Prx1-expressing OCPs. This finding
is perhaps surprising considering that Prx1-expressing
cells make up such a small percentage of the total cells
in the periosteum, yet have such a drastic impact on
adult bone formation and fracture repair. Similarly, in
the aforementioned repeated fracture study, the authors
identified very few self-renewing Prx1-expressing cells in
new periosteum following fracture, but these rare cells
still made up the vast majority of callus cells in subse-
quent fractures [12]. Despite the low percentage and
some cell death due to sorting, these cells rapidly prolif-
erate within 24 h and we were able to generate enough
cells for a typical fluid flow study (about 500 k) within a
week. These cells continued to proliferate at the same rate
and were passaged up to 10 times spanning 2 months after
sorting. The percentage of Prx1-expressing cells increased
when given more time in culture before sorting, suggest-
ing these OCPs proliferate at a higher rate than other cells
of the periosteum. This extraction is faster or similar to
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the amount of time it takes to isolate primary MSCs [50].
Moreover, MSCs require further guidance in vitro to dif-
ferentiate into osteoblasts, whereas periosteal OCPs are
preprogrammed towards an osteoblastic or chondrogenic
lineage and therefore require less culture time [11, 51].
Further work must be done to compare human periosteal
progenitors and MSCs to obtain a definitive answer but,
minimally, our preliminary observations suggest that the
periosteum is a promising source for osteogenic precur-
sors that can be expanded for bone regeneration.
Manipulating the primary cilium is a potential mech-
anism to enhance periosteal OCP function. In our previ-
ous study, mice containing a Prx1-driven cilium
knockout formed less bone in response to ulnar loading
(Chen et al., manuscript submitted). Specifically, mu-
tants had attenuated mineralization rates, indicating that
the primary cilium is important for matrix deposition by
OCP-derived osteoblasts. Thus, restoring or enhancing
periosteal primary cilium function is critical for perios-
teal progenitors to proliferate and differentiate during
bone formation. The primary cilium is thought to serve
as a signaling nexus for the cell and is known to mediate
several pathways critical to cell function. For example,
the cilium was recently found to regulate TGF-β signal-
ing [52, 53], which is important for periosteal progenitor
proliferation and differentiation [54], bone matrix pro-
tein synthesis [55], and load-induced bone formation
[32]. The primary cilium also mediates Wnt signaling, a
pathway critical to osteoblast lineage commitment and
skeletal homeostasis [56]. In the aforementioned study,
Yukata et al. determined that intermittent PTH 1–34
treatment stimulated Wnt signaling, increasing the num-
ber of participating periosteal progenitor cells in the
fracture callus [41]. We speculate that if the primary
cilium is potentiated, its associated signaling pathways
will be enriched. Indeed, we recently demonstrated that
pharmacologically lengthening osteocyte primary cilia in
vitro enhances their mechanosensitivity and, conse-
quently, their osteogenic response to mechanical stimu-
lation [57]. This mechanism has been confirmed in
other cell types [58], suggesting that potentiating cilia
generally enhances the function of cells, including peri-
osteal progenitors. More importantly, this pharmaco-
logical treatment was able to recover cilium structure
and sensitivity in cells with impaired cilia, making it a vi-
able option for stimulating older progenitor cells.
Conclusion
Collectively, our results encourage the use of periosteal
Prx1-expressing OCPs and manipulation of their pri-
mary cilia for tissue engineering and regenerative medi-
cine (TERM) applications. The mechanisms for adult
bone formation are highly similar between mice and
humans and so our work provides important insights for
potential therapeutics. The current preferred method for
bone TERM in patients is to implant a scaffold seeded
with MSCs that have been extracted and guided to an
osteoblastic lineage in vitro [6]. Periosteal progenitors
are potentially better suited for bone tissue regeneration
because they preferentially provide both osteoblasts and
chondrocytes [28]. Our studies demonstrate that perios-
teal OCPs are prevalent and active in skeletally mature
adult mice. More importantly, we identified that perios-
teal OCPs are not only inherently involved in, but are
perhaps the dominant contributor to, load-induced adult
bone formation. This importantly builds upon recent
work demonstrating that periosteum-derived progenitors
are the most prevalent cell source in the fracture callus
and uniquely dominate repair after multiple fractures
[28]. This suggests periosteal OCPs have a surprising
ability to proliferate and generate new bone in vivo, even
though they represent a mere 3% of cells found in the
periosteum. Additionally, OCPs are easier to extract
from the subcutaneous periosteum in several locations
compared with MSCs, and can be expanded in culture in
vitro. We also found that primary cilia are an important
contributor to the osteogenic nature of OCPs. OCP pri-
mary cilia are therefore attractive therapeutic targets since
sensory organelles can be manipulated in vitro to enhance
osteogenesis [57, 58]. Overall, this Prx1-expressing perios-
teal OCP population satisfies the criteria for a
much-desired progenitor source and should be considered
a strong contender for future research and clinical appli-
cations in skeletal tissue regeneration.
Additional file
Additional file 1: Figure S1. Mice lacking OCPs lack load-induced
osteoblast differentiation at the periosteal surface. H&E stains of tissue
sections from control (left) and experimental animals (right). Control
animals exhibited differentiating osteoblasts at the periosteal surface (left,
black box). These differentiating osteoblasts were not observed in animals
with ablated OCPs (right) or the nonloaded contralateral limbs of
both groups (data not shown). Micrographs were collected at 20X
magnification. (TIF 7918 kb)
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